Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zhenquan Lu, Jian Hou, Xiao Li, Jun Zhou, Bingfeng Luo, Songwu Liang, Richard K Lo, Tak Man Wong & Guan-Ming Kuang. (2022) Exosome-Derived miRNAs as Potential Biomarkers for Prostate Bone Metastasis. International Journal of General Medicine 15, pages 5369-5383.
Read now
Read now
Articles from other publishers (28)
Haosheng Li, Haoran Feng, Tao Zhang, Junwei Wu, Xiaonan Shen, Shuiyu Xu, Lianghui Xu, Shaodong Wang, Yaqi Zhang, Wenqing Jia, Xiaopin Ji, Xi Cheng & Ren Zhao. (2024) CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib. Molecular Cancer 23:1.
Crossref
Crossref
Jing Zhu, Qian Li, Zhongping Wu, Wei Xu & Rilei Jiang. (2024) Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer. Non-coding RNA Research 9:1, pages 262-276.
Crossref
Crossref
Tao Xu, Mengqiu Xiong, Qiwei Hong, Bei Pan, Mu Xu, Ying Wang, Yalan Sun, Huiling Sun, Yuqin Pan, Shukui Wang & Bangshun He. (2024) Hsa_circ_0007990 promotes breast cancer growth via inhibiting YBX1 protein degradation to activate E2F1 transcription. Cell Death & Disease 15:2.
Crossref
Crossref
Na Hao, Mingyang Li, Jiachen Wang, Yichen Song, Yuelei Zhao, Ling Zhang, Xinyu Yang, Ligang Chen, Junchi Ma, Qingge Jia & Fang Sui. (2023) High PGAP3 expression is associated with lymph node metastasis and low CD8+T cell in patients with HER2+ breast cancer. Pathology - Research and Practice 251, pages 154890.
Crossref
Crossref
Guoli Shao, Xulong Fan, Pusheng Zhang, Xuewen Liu, Lei Huang & Shufeng Ji. (2022) Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis. Cell Biology and Toxicology 39:5, pages 2183-2205.
Crossref
Crossref
Shikha Mudgal, Pranoy Paul, Bina Ravi, Shruti Agrawal, Arnav Kalra, Shalinee Rao & Nilotpal Chowdhury. (2023) Detecting Human Epidermal Growth Factor Receptor 2 (HER2) Amplification: Proof of Concept of an Alternative Approach. Cureus.
Crossref
Crossref
Alina Catalina Palcau, Renata Brandi, Nikolay Hristov Mehterov, Claudio Botti, Giovanni Blandino & Claudio Pulito. (2023) Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment. Cancers 15:16, pages 4181.
Crossref
Crossref
Mohammadjavad Karimi Taheri, Sogol Ghanbari, Akram Gholipour, Taraneh Givi & Majid Sadeghizadeh. (2023)
LINC01116
affects patient survival differently and is dissimilarly expressed in
ER
+ and
ER
− breast cancer samples
. Cancer Reports 6:8.
Crossref
Crossref
Apurva Jaiswal, Neha Kaushik, Eun Ha Choi & Nagendra Kumar Kaushik. (2023) Functional impact of non-coding RNAs in high-grade breast carcinoma: Moving from resistance to clinical applications: A comprehensive review. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:4, pages 188915.
Crossref
Crossref
Alyaa Dawoud, Zeina Ihab Zakaria, Hannah Hisham Rashwan, Maria Braoudaki & Rana A. Youness. (2023) Circular RNAs: New layer of complexity evading breast cancer heterogeneity. Non-coding RNA Research 8:1, pages 60-74.
Crossref
Crossref
Zhuorong Chen, Xumeng Gong, Chun Cheng, Yinghui Fu, Wanming Wu & Zhihui Luo. (2023) Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis. Clinical Breast Cancer 23:2, pages 143-154.
Crossref
Crossref
Ziwei Zhao, Xue Han, Chen Nie, Shan Lin, Jingwei Wang & Hong Fang. (2023) Circ_0008784 activates Wnt/β-catenin pathway to affect the proliferation and apoptosis of triple-negative breast cancer cells. Pathology - Research and Practice 241, pages 154185.
Crossref
Crossref
Chen Xue, Ganglei Li, Qiuxian Zheng, Xinyu Gu, Zhengyi Bao, Juan Lu & Lanjuan Li. (2022) The functional roles of the circRNA/Wnt axis in cancer. Molecular Cancer 21:1.
Crossref
Crossref
Janusz Matuszyk. (2022) MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. Molecular Medicine 28:1.
Crossref
Crossref
Zahra Foruzandeh, Davood Ghavi Dorabadi, Farzaneh Sadeghi, Fatemeh Zeinali-Sehrig, Mohammad Zaefizadeh, Yazdan Rahmati & Mohammad Reza Alivand. (2022) Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review. Molecular Biology Reports 49:10, pages 9825-9840.
Crossref
Crossref
Xiaochen Zan, Wenfang Li, Geng Wang, Jie Yuan, Yongbiao Ai, Jun Huang & Zhi Li. (2022) Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p/LDHA pathway. Reproductive Biology and Endocrinology 20:1.
Crossref
Crossref
Mingwei Tang, Fengbo Wang, Ke Wang, Yuan Jiang & Qiongfen Wang. (2022) Circ_0058063 promotes progression of thyroid cancer by sponging miR-330-3p/SDC4 axis. Anti-Cancer Drugs 33:7, pages 642-651.
Crossref
Crossref
Nadine S. van den Ende, Marcel Smid, Annemieke Timmermans, Johannes B. van Brakel, Tim Hansum, Renée Foekens, Anita M. A. C. Trapman, Bernadette A. M. Heemskerk-Gerritsen, Agnes Jager, John W. M. Martens & Carolien H. M. van Deurzen. (2022) HER2-low breast cancer shows a lower immune response compared to HER2-negative cases. Scientific Reports 12:1.
Crossref
Crossref
Utpalendu Paul & Satarupa Banerjee. (2022) The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer. Molecular Biology Reports 49:7, pages 6899-6918.
Crossref
Crossref
Yusufu Maimaiti, Ning Zhang, Yunke Zhang, Jing Zhou, Haiping Song & Shuntao Wang. (2022)
CircFAM64A
enhances cellular processes in triple‐negative breast cancer by targeting the
miR
‐149‐5p/
CDT1
axis
. Environmental Toxicology 37:5, pages 1081-1092.
Crossref
Crossref
Qian Tang, Feidu Zhou, Chuanguang Yang, Jue Dai, Jintao Li & Yanxian He. (2022) CircINTS4 Facilitates Chemoresistance of TNBC by Competitively Binding miR-129-5p/POM121 Axis. Journal of Oncology 2022, pages 1-15.
Crossref
Crossref
Abdollah Jafarzadeh, Mohammad Hossein Paknahad, Maryam Nemati, Sara Jafarzadeh, Maryam Mahjoubin-Tehran, Ali Rajabi, Layla Shojaie & Hamed Mirzaei. (2022) Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target. Biomedicine & Pharmacotherapy 146, pages 112600.
Crossref
Crossref
Deepti Singh, Prashant Kesharwani, Nabil A. Alhakamy & Hifzur R. Siddique. (2022) Accentuating CircRNA-miRNA-Transcription Factors Axis: A Conundrum in Cancer Research. Frontiers in Pharmacology 12.
Crossref
Crossref
Meilan Zhang, Xue Bai, Xuemei Zeng, Jiangrong Liu, Feng Liu & Zhiwei Zhang. (2021) circRNA-miRNA-mRNA in breast cancer. Clinica Chimica Acta 523, pages 120-130.
Crossref
Crossref
Juan Xu, Xiyi Chen, Yu Sun, Yaqian Shi, Fang Teng, Mingming Lv, Chen Liu & Xuemei Jia. (2021) The Regulation Network and Clinical Significance of Circular RNAs in Breast Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Jie Liu, Gang Zhao, Xin-Li Liu, Ge Zhang, Shi-Qi Zhao, Shi-Long Zhang, Li-Heng Luo, Da-Chuan Yin & Chen-Yan Zhang. (2021) Progress of non-coding RNAs in triple-negative breast cancer. Life Sciences 272, pages 119238.
Crossref
Crossref
Tian Jun, Wang Chen, Cheng Hailing, Wang Ning & Cao Qinxue. (2021) The novel circular RNA circ-PGAP3 retards cervical cancer growth by regulating the miR-769-5p/p53 axis. Human Cell 34:3, pages 878-888.
Crossref
Crossref
Lijuan Lyu, Shizhen Zhang, Yujiao Deng, Meng Wang, Xinyue Deng, Si Yang, Ying Wu & Zhijun Dai. (2021) Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer. Journal of Hematology & Oncology 14:1.
Crossref
Crossref